<DOC>
	<DOC>NCT00661115</DOC>
	<brief_summary>To investigate the efficacy and safety of vardenafil in men with erectile dysfunction.</brief_summary>
	<brief_title>To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Men 21 years or above with ED for more than 6 months with normal libido and stable heterosexual relationship of at least 6 months having at least a 50% failure rate of sexual intercourse attempts during the runin phase Subjects with penile abnormalities, hypogonadism, history of unstable angina pectoris for 6 months or less, myocardial infarction, life threatening arrhythmia and history of unresponsiveness to sildenafil were excluded. Diabetic subjects with hemoglobin A1c (HbA1c) more than 12% were also excluded. Subjects could not be on androgens/antiandrogens or alpha blockers.</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Sexual Dysfunction</keyword>
</DOC>